Anika Therapeutics Inc. (ANIK)
14.02
0.55 (4.08%)
At close: Apr 17, 2025, 3:59 PM
13.53
-3.53%
After-hours: Apr 17, 2025, 04:29 PM EDT
4.08% (1D)
| Bid | 13 |
| Market Cap | 198.75M |
| Revenue (ttm) | 119.91M |
| Net Income (ttm) | -56.38M |
| EPS (ttm) | -0.6 |
| PE Ratio (ttm) | -23.37 |
| Forward PE | 25.14 |
| Analyst | Hold |
| Ask | 15.05 |
| Volume | 95,492 |
| Avg. Volume (20D) | 73,433 |
| Open | 13.59 |
| Previous Close | 13.47 |
| Day's Range | 13.54 - 14.09 |
| 52-Week Range | 12.83 - 29.12 |
| Beta | 0.81 |
About ANIK
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain manageme...
Industry Medical - Devices
Sector Healthcare
IPO Date May 3, 1993
Employees 288
Stock Exchange NASDAQ
Ticker Symbol ANIK
Analyst Forecast
According to 2 analyst ratings, the average rating for ANIK stock is "Hold." The 12-month stock price forecast is $22, which is an increase of 56.92% from the latest price.
Stock ForecastsNext Earnings Release
Anika Therapeutics Inc. is scheduled to release its earnings on May 7, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
-30.67%
Anika Therapeutics shares are trading lower after ...
Unlock content with
Pro Subscription
